NLRP3 and rheumatoid arthritis: With increasing evidence supporting the importance of the NLRP3 inflammasome in RA pathogenesis [10,33,34,35,36,37,38,39,40,41,42], there has been significant interest in developing therapeutic agents targeting the components of NLRP3 inflammasome signaling [52,53,54].